Veteran industrialist and the founder chairman of Ahmedabad-based privately held pharmaceutical firm Cadila Pharmaceuticals Ltd Indravadan A Modi passed away in Ahmedabad on Monday. The 87 year old who was suffering from respiratory disorder and was admitted at a city hospital breathed his last at around 5:00 pm today.
Born in a small village of Hansot of Bharuch district in South Gujarat on February 18, 1926, Modi pursued higher studies at Bombay University where his chosen area of study was pharmaceuticals and fine chemicals. The idea to manufacture medicines germinated in his mind at that time and Modi quit his job as a chemist in a chemical manufacturing unit and launched Cadila Laboratories in 1951 as a partnership with a school friend Ramanbhai B Patel. The two friends, however, parted ways in 1995 and Cadila Pharmaceuticals came into being.
Typical of a start-up Cadila had no depth of management.Modi was the producer, promoter, distributor and deliveryman-all rolled into one. He was also the manager, administrator and accountant of his business. His wife and grand mother helped him in chores up to the packing stage. He drew a paltry Rs 250 a month for sustenance and whatever additional revenues that were generated were ploughed back into business.
Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, a company release said. Over the last six decades, the company has been developing and manufacturing pharmaceutical products in India and selling and distributing these in over 90 other countries around the world. An integrated healthcare solutions provider with pharmaceutical product basket, the company caters to over 45 therapeutic areas that include cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals.
Modi is revered in the Indian Pharmaceutical Industry as the Champion of Indian Patents Act, 1970. He played a major role in giving shape to the 1986 Drug Policy of Government of India.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
